Bent A Jacobsen
Overview
Explore the profile of Bent A Jacobsen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
354
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Larsen L, Jess T, Drewes A, Dige A, Fallingborg J, Jacobsen B, et al.
Eur J Gastroenterol Hepatol
. 2019 May;
31(8):964-967.
PMID: 31094854
Objective: Loss of infliximab (IFX) effect is a clinical challenge in the management of patients with Crohn's disease (CD), but this can potentially be reduced with azathioprine (AZA) or with...
2.
Engelke C, Lange-Asschenfeldt C, Peter S, Kahl K, Frasch K, Larsen J, et al.
Eur Psychiatry
. 2018 Jan;
48:65-70.
PMID: 29331602
Weight gain among psychiatric inpatients is a widespread phenomenon. This change in body mass index (BMI) can be caused by several factors. Based on recent research, we assume the following...
3.
Frederik Dahlerup J, Jacobsen B, van der Woude J, Bark L, Thomsen L, Lindgren S
Scand J Gastroenterol
. 2016 Jun;
51(11):1332-8.
PMID: 27326766
Objective: Iron isomaltoside (Monofer(®)) is a high-dose intravenous iron preparation with good tolerability and efficacy in inflammatory bowel disease (IBD) patients with iron deficiency anaemia (IDA). This trial evaluates the...
4.
Steenholdt C, Brynskov J, Thomsen O, Munck L, Fallingborg J, Christensen L, et al.
Dig Dis Sci
. 2015 Feb;
60(9):2762-70.
PMID: 25673037
Background: In Crohn's disease patients failing infliximab therapy, interventions defined by an algorithm based on infliximab and anti-infliximab antibody measurements have proven more cost-effective than intensifying the infliximab regimen. Aim:...
5.
Jess T, Horvath-Puho E, Fallingborg J, Rasmussen H, Jacobsen B
Am J Gastroenterol
. 2013 Aug;
108(12):1869-76.
PMID: 23978954
Objectives: Population-based studies of site-specific cancer risk in patients with inflammatory bowel disease (IBD) according to IBD phenotype and treatment are lacking. We studied cancer risk in a well-characterized population-based...
6.
Larsen J, Andersen U, Becker T, Bickel G, Bork B, Cordes J, et al.
Aust N Z J Psychiatry
. 2012 Oct;
47(3):250-8.
PMID: 23076547
Objective: People with psychiatric diseases have a severely increased risk for physical morbidity and premature death from physical diseases. The aims of the study were to investigate the occurrence of...
7.
Andersen V, Ernst A, Sventoraityte J, Kupcinskas L, Jacobsen B, Krarup H, et al.
BMC Med Genet
. 2011 Oct;
12:139.
PMID: 21995314
Background: Differences in the genetic architecture of inflammatory bowel disease between different European countries and ethnicities have previously been reported. In the present study, we wanted to assess the role...
8.
Andersen V, Christensen J, Ernst A, Jacobsen B, Tjonneland A, Krarup H, et al.
World J Gastroenterol
. 2011 Jan;
17(2):197-206.
PMID: 21245992
Aim: To investigate the contribution of polymorphisms in nuclear receptors to risk of inflammatory bowel disease (IBD). Methods: Genotypes of nuclear factor (NF)-κB (NFKB1) NFκB -94ins/del (rs28362491); peroxisome proliferator-activated receptor...
9.
Ernst A, Andersen V, Ostergaard M, Jacobsen B, Pedersen I, Drewes A, et al.
Eur J Gastroenterol Hepatol
. 2011 Jan;
23(3):269-74.
PMID: 21228703
Introduction: Chronic inflammatory bowel disease (IBD) is characterized by recurrent inflammation of the intestinal mucosa. Reactive molecules play a central role in altering the intestinal permeability, which may induce or...
10.
Andersen V, Nimmo E, Krarup H, Drummond H, Christensen J, Ho G, et al.
Inflamm Bowel Dis
. 2010 Aug;
17(4):937-46.
PMID: 20803508
Background: Inflammatory bowel diseases (IBDs) are a result of interactions between luminal pathogens and the intestinal immune response. Cyclooxygenase-2 (COX-2) plays a key role in the regulation of the inflammatory...